CUTR
NASDAQCutera Inc.
Latest news
25 items- PRCutera® Successfully Completes Restructuring Transaction and Moves Forward with Enhanced Capital StructureEmerges from Chapter 11 as a stronger company, well positioned for long-term growth Continuing to provide best-in-class aesthetic and dermatology solutions to customers CUTERA, INC., ("Cutera" or "the Company"), a leading provider of aesthetic and dermatology solutions, today announced that the Company has successfully completed its financial restructuring process and emerged from Chapter 11. Cutera emerges with a significantly stronger balance sheet, well positioned to drive innovation and growth. Through this process, Cutera has reduced its debt by nearly $400 million, or over 90%, and raised $65 million in new money financing from its existing lenders. "Today marks a significant mile
- SECSEC Form EFFECT filed by Cutera Inc.EFFECT - CUTERA INC (0001162461) (Filer)
- SECSEC Form POS AM filed by Cutera Inc.POS AM - CUTERA INC (0001162461) (Filer)
- SECSEC Form 25 filed by Cutera Inc.25 - CUTERA INC (0001162461) (Filer)
- PRCutera Announces Voluntarily Delisting from NasdaqCutera, Inc. ("Cutera" or the "Company") (NASDAQ:CUTR) today announced that it has formally notified The Nasdaq Stock Market LLC ("Nasdaq") of its intent to voluntarily delist its common stock from the Nasdaq Global Select Market. Cutera expects to file a Form 25 with the Securities and Exchange Commission (the "SEC") relating to the voluntary delisting of its common stock on or about March 20, 2025. The Company expects the delisting of the common stock to be effective on or about March 30, 2025. Following such delisting, the Company intends to file a Form 15 with the SEC to indefinitely suspend the Company's reporting obligations under the Securities Exchange Act of 1934, as amended. The s
- SECCutera Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing8-K - CUTERA INC (0001162461) (Filer)
- SECSEC Form S-8 POS filed by Cutera Inc.S-8 POS - CUTERA INC (0001162461) (Filer)
- SECSEC Form S-8 POS filed by Cutera Inc.S-8 POS - CUTERA INC (0001162461) (Filer)
- SECSEC Form S-8 POS filed by Cutera Inc.S-8 POS - CUTERA INC (0001162461) (Filer)
- SECSEC Form S-8 POS filed by Cutera Inc.S-8 POS - CUTERA INC (0001162461) (Filer)
- SECSEC Form S-8 POS filed by Cutera Inc.S-8 POS - CUTERA INC (0001162461) (Filer)
- SECSEC Form S-8 POS filed by Cutera Inc.S-8 POS - CUTERA INC (0001162461) (Filer)
- SECSEC Form S-8 POS filed by Cutera Inc.S-8 POS - CUTERA INC (0001162461) (Filer)
- SECSEC Form S-8 POS filed by Cutera Inc.S-8 POS - CUTERA INC (0001162461) (Filer)
- SECSEC Form S-8 POS filed by Cutera Inc.S-8 POS - CUTERA INC (0001162461) (Filer)
- SECSEC Form S-8 POS filed by Cutera Inc.S-8 POS - CUTERA INC (0001162461) (Filer)
- SECSEC Form S-8 POS filed by Cutera Inc.S-8 POS - CUTERA INC (0001162461) (Filer)
- SECSEC Form S-8 POS filed by Cutera Inc.S-8 POS - CUTERA INC (0001162461) (Filer)
- SECSEC Form S-3DPOS filed by Cutera Inc.S-3DPOS - CUTERA INC (0001162461) (Filer)
- PRCutera Takes Steps to Strengthen Financial Foundation and Position the Company for Long-Term SuccessEnters into agreement to reduce debt by nearly $400 million and raise $65 million of new money from existing lenders Implementing pre-packaged financial restructuring plan with strong support of lenders, expected to emerge expeditiously within 60 days Continues to operate as usual and provide best-in-class aesthetic and dermatology solutions to customers CUTERA, INC., ("Cutera" or "the Company"), a leading provider of aesthetic and dermatology solutions, today announced that it is initiating a restructuring transaction with the support of a group of existing lenders, representing approximately 74% of the Company's notes, to strengthen its balance sheet and position Cutera for long-term s
- SECCutera Inc. filed SEC Form 8-K: Bankruptcy or Receivership, Regulation FD Disclosure8-K - CUTERA INC (0001162461) (Filer)
- INSIDERChief Legal Officer Patton Stephana Eilene covered exercise/tax liability with 623 shares, decreasing direct ownership by 0.80% to 77,216 units (SEC Form 4)4 - CUTERA INC (0001162461) (Issuer)
- INSIDERChief Executive Officer Harris Taylor C. covered exercise/tax liability with 4,620 shares, decreasing direct ownership by 2% to 255,744 units (SEC Form 4)4 - CUTERA INC (0001162461) (Issuer)
- INSIDERSEC Form 3 filed by new insider Wierbicki Paul3 - CUTERA INC (0001162461) (Issuer)
- SECCutera Inc. filed SEC Form 8-K: Leadership Update8-K - CUTERA INC (0001162461) (Filer)
CUTR FAQ
7 questionsWhat does Cutera Inc. do?
Cutera, Inc., a medical device company, engages in the research, development, manufacture, marketing, and servicing of laser and energy-based aesthetics systems for practitioners worldwide. The company offers truSculpt flex, a bio-electrical muscle stimulation device to treat patients at all fitness levels; truSculpt for the non-surgical body sculpting market; Juliet, a laser for women's intimate health; Secret RF, a fractional radio frequency microneedling device for skin revitalization; and enlighten platform, a laser system that is used for tattoo removal, as well as for the treatment of...Where does CUTR stock trade?
Cutera Inc. (CUTR) is listed on NASDAQ.What sector and industry is CUTR in?
Cutera Inc. operates in the Health Care sector, Biotechnology: Electromedical & Electrotherapeutic Apparatus industry.When did Cutera Inc. go public?
Cutera Inc. (CUTR) completed its IPO in 2004.What are analysts saying about CUTR?
Cutera Inc. has had 8 recent analyst actions on file. The most recent action was from William Blair: Mkt Perform on 2024-03-22. Recent price targets range from $1400.00 to $3300.00.What companies are similar to CUTR?
Notable peers in the same industry include MDT (Medtronic plc.), MASI (Masimo Corporation), SEAS (SeaWorld Entertainment Inc.), LIVN (LivaNova PLC), ITGR (Integer Holdings Corporation). Compare CUTR side-by-side with any of them on Quantisnow.How can I track CUTR on Quantisnow?
Quantisnow aggregates Cutera Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow CUTR to receive live email and push alerts on every new disclosure.